CSM Corbion NV

Corbion reports the progress of its share buyback program 3 November – 7 November 2025

Corbion reports the progress of its share buyback program 3 November – 7 November 2025

Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025.

During the week of 3 November up to and including 7 November 2025 a total of 124.786 shares were repurchased at an average price of €17.6422 for a total amount of €2,201,503.94

To date, the total consideration for shares repurchased amounts to €9,417,268.66 representing 94.17% of the overall share buyback program.

Corbion publishes on a weekly basis every Monday, an overview of the progress of the share buyback program on its website: /Investor-relations/shareholder-information

This overview contains detailed information on the daily amount of repurchased shares and individual share purchase transactions.

Attachment



EN
10/11/2025

Underlying

CSMCorbion NV

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Corbion NV

 PRESS RELEASE
Free
CSM CORBION NV

Corbion published agenda for AGM

Corbion published agenda for AGM Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 13 May 2026. The full AGM agenda together with explanatory notes is available on Corbion's under Investor relations --> Shareholder information --> Shareholder meetings. Attachment

1h / 59m 1 EN
Jean-François Granjon ... (+3)
  • Jean-François Granjon
  • Louis Boujard
  • CFA
AUTN AUTONEUM HOLDING AG
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
21h / 53m 21h / 53m 1 EN
Jean-François Granjon ... (+3)
  • Jean-François Granjon
  • Louis Boujard
  • CFA
AUTN AUTONEUM HOLDING AG
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
22h / 23m 22h / 23m 1 FR
Robert Jan Vos
  • Robert Jan Vos
03/31/26 March 31, 2026 1 EN
Reg Watson ... (+2)
  • Reg Watson
  • CFA
CSM CORBION NV

Corbion/Goldilocks scenario extends/HOLD

Since our 12-month target price upgrade to €18.60 and change in recommendation from Sell to HOLD on 17 November 2025, Corbion has delivered its Capital Markets Day and full year results. Corbion confirmed at its 2025 results that the company had taken advantage of the low sugar price to hedge all its exposure for 2026 and 75% for 2027. This extends the Goldilocks scenario of lower costs and higher revenues from 2026 into 2027 and supports approximately half of the company's guided adj. EBITDA ma...

03/31/26 March 31, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch